Atropine sulfate ophthalmic- LitePharm Tech
Alternative Names: LPTATLatest Information Update: 09 Mar 2023
At a glance
- Originator LitePharmTech
- Class Alkaloids; Antidotes; Cardiovascular therapies; Eye disorder therapies; Small molecules; Tropanes
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Myopia
Most Recent Events
- 06 Mar 2023 Chemical structure information added
- 25 May 2022 Phase-III clinical trials in Myopia (In children) in South Korea (Ophthalmic) (NCT05529056)